SCHEMBL7012889

SCHEMBL7012889

Cc1ccc2nc(-c3ccccc3C#N)ncc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.45
GAA P10253 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
PKM P14618 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GABRA1 P14867 3/20 0.41
GABRG2 P18507 3/20 0.41
GABRB3 P28472 3/20 0.41
GABRA2 P47869 3/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
POLB P06746 2/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
TSHR P16473 2/20 0.40
NQO2 P16083 1/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014298 0.78 MAOB (0.46) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL8482877 0.77 KDM4E (0.47) KDM4EGAANPSR1RXFP1PKM
SCHEMBL26337264 0.77 TSHR (0.45) TDP1GABRA1GABRG2GABRB3GABRA2
SCHEMBL17691569 0.74 MAOA (0.58) KDM4EALDH1A1NQO2MAOAMAOB
SCHEMBL30718705 0.72 PKM (0.44) KDM4EGAANPSR1RXFP1PKM
SCHEMBL27141158 0.72 PKM (0.44) KDM4EGAANPSR1RXFP1PKM
SCHEMBL29669934 0.70 GABRG2 (0.36) KDM4EMEN1KMT2ATDP1GABRA1
SCHEMBL8776904 0.70 CYP1A2 (0.37) KDM4EGAAGABRA1GABRG2GABRB3
SCHEMBL21899538 0.70 TSHR (0.48) KDM4EGAAGABRA1GABRG2GABRB3
SCHEMBL7624975 0.70 GRM2 (0.49) KDM4EGAANPSR1RXFP1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed